Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-23
DOI
10.1002/mc.22893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma
- (2018) Brian K. Chung et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells
- (2018) Suyanee Thongchot et al. CANCER LETTERS
- Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells
- (2018) Eunji Im et al. LIFE SCIENCES
- Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins
- (2017) Rokas Račkauskas et al. ONCOLOGY REPORTS
- Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand
- (2017) Sunitta Saensa-ard et al. TUMOR BIOLOGY
- Dihydroartemisinin Exerts Anti-Tumor Activity by Inducing Mitochondrion and Endoplasmic Reticulum Apoptosis and Autophagic Cell Death in Human Glioblastoma Cells
- (2017) Chengbin Qu et al. Frontiers in Cellular Neuroscience
- Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis
- (2017) Zili Zhang et al. Cell Death & Disease
- Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells
- (2017) Siriwoot Butsri et al. Oncology Letters
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway
- (2016) Qin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents
- (2016) Papavee Samatiwat et al. TUMOR BIOLOGY
- PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells
- (2016) Suratchanee Phadngam et al. Oncotarget
- Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells
- (2015) Guiqi Qin et al. APOPTOSIS
- Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts
- (2015) Chiara Raggi et al. JOURNAL OF HEPATOLOGY
- Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
- (2015) ZE-SHUN ZHANG et al. Oncology Letters
- Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy
- (2014) Xue Feng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents
- (2014) Ponsilp Zeekpudsa et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Methylation analysis of the DAPK1 gene in imatinib-resistant chronic myeloid leukemia patients
- (2014) SELCEN CELIK et al. Oncology Letters
- Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin
- (2013) Xiao-Xue Du et al. BIOMEDICINE & PHARMACOTHERAPY
- Dihydroartemisinin induces autophagy by suppressing NF-κB activation
- (2013) Wei Hu et al. CANCER LETTERS
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting
- (2013) Alphonse E. Sirica et al. HEPATOLOGY
- Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis
- (2013) Kelly Devereaux et al. PLoS One
- Beclin 1 Deficiency Correlated with Lymph Node Metastasis, Predicts a Distinct Outcome in Intrahepatic and Extrahepatic Cholangiocarcinoma
- (2013) Tian-Tian Wang et al. PLoS One
- Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
- (2012) Chris Zhiyi Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Genetic profiling of intrahepatic cholangiocarcinoma
- (2012) Jesper B. Andersen et al. CURRENT OPINION IN GASTROENTEROLOGY
- Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands
- (2012) Vincenzo Cardinale et al. HEPATOLOGY
- Development of artemisinin compounds for cancer treatment
- (2012) Henry C. Lai et al. INVESTIGATIONAL NEW DRUGS
- Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
- (2011) Ning Gao et al. APOPTOSIS
- Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma
- (2011) Li-Wei Dong et al. Autophagy
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
- (2011) Junli Liu et al. CELL
- PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk
- (2011) A Eisenberg-Lerner et al. CELL DEATH AND DIFFERENTIATION
- Cell death by autophagy: facts and apparent artefacts
- (2011) D Denton et al. CELL DEATH AND DIFFERENTIATION
- Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
- (2011) Maria P. Crespo-Ortiz et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2
- (2010) Hyunho Yoon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
- (2010) Shuang-Jia Wang et al. CANCER LETTERS
- The Beclin 1 interactome
- (2010) Congcong He et al. CURRENT OPINION IN CELL BIOLOGY
- Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
- (2010) R. Handrick et al. MOLECULAR CANCER THERAPEUTICS
- Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
- (2009) Hui-Jun Zhou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
- (2009) Ji-Hui Du et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of BNIP3 and NIX in cell death, autophagy and mitophagy
- (2009) J Zhang et al. CELL DEATH AND DIFFERENTIATION
- DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy
- (2009) Einat Zalckvar et al. EMBO REPORTS
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
- (2008) J. Hou et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search